Gestational Diabetes-like Fuels Impair Mitochondrial Function and Long-Chain Fatty Acid Uptake in Human Trophoblasts

Kyle M Siemers1, Lisa A Joss-Moore2, Michelle L Baack3,4

  • 1Sanford School of Medicine, University of South Dakota, 414 E. Clark Street, Vermillion, SD 57069, USA.

Insights

Gestational diabetes mellitus (GDM) impairs placental fatty acid (FA) uptake and lipid droplet storage, especially with combined high glucose and lipids. This contributes to fetal long-chain polyunsaturated fatty acid (LCPUFA) deficiency and adverse outcomes.

Area of Science:

  • Reproductive Biology
  • Maternal-Fetal Medicine
  • Cellular Metabolism

Background:

  • Gestational diabetes mellitus (GDM) leads to maternal hyperglycemia and hyperlipidemia.
  • Infants exposed to GDM face risks of essential long-chain polyunsaturated fatty acid (LCPUFA) deficiency.
  • Mechanisms linking diabetic fuels to placental fatty acid (FA) transport and lipid droplet dynamics are unclear.

Purpose of the Study:

  • To investigate how high glucose and high lipid conditions, individually and combined, affect trophoblast function.
  • To analyze the impact on trophoblast growth, viability, mitochondrial function, FA uptake, and lipid droplet partitioning.
  • To elucidate how GDM-associated metabolic changes disrupt placental lipid handling.

Main Methods:

  • Utilized BeWo and primary isolated cytotrophoblasts (CTBs) exposed to varying glucose and lipid concentrations.
  • Assessed trophoblast growth, viability, and apoptosis.
  • Measured mitochondrial bioenergetics and BODIPY-labeled fatty acid (FA) uptake, including specific chain lengths (C12, C16).
  • Analyzed lipid droplet count, area, and subcellular localization.

Main Results:

  • FA uptake was sensitive to acyl chain length and media exposure in trophoblasts.
  • Combined high glucose and high lipid exposure increased mitochondrial protein but impaired respiratory capacity and reduced viability due to apoptosis.
  • Trophoblasts exposed to combined conditions showed reduced uptake of BODIPY C16 into cells and lipid droplets, with altered lipid droplet characteristics, unlike individual exposures.

Conclusions:

  • Combined high glucose and lipid conditions in GDM significantly disrupt placental FA transport and lipid droplet dynamics.
  • These disruptions impair trophoblast function and viability, potentially explaining LCPUFA deficiency in neonates.
  • Findings highlight the complex impact of GDM on placental lipid metabolism, contributing to adverse pregnancy outcomes.

Related Concept Videos

Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
872
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.4K